ORIC
Oric Pharmaceuticals, Inc.Company with tickers: ORIC
CIK
1796280
CUSIP
68622P109
Shares Outstanding
103,517,562
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $39,619,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| Research & Development | — | ||||
| Operating Income | $-39,619,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| Net Income | $-35,767,000 | USD | 2026-03-31 | 10-Q | 2026-05-04 |
| EPS (Basic) | $-0.34 | USD/shares | 2026-03-31 | 10-Q | 2026-05-04 |
| EPS (Diluted) | $-0.34 | USD/shares | 2026-03-31 | 10-Q | 2026-05-04 |